ReviewEuropean cardiology2026
Preterm Birth and Maternal Cardiovascular Risk.
Review in European cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preterm birth (PTB) is increasingly recognised not only for its immediate perinatal risks but also as a significant predictor of long-term cardiovascular disease. Emerging evidence from large observational studies and meta-analyses demonstrates that women with a history of PTB face substantially higher risks of hypertension, diabetes, coronary heart disease, stroke and cardiovascular mortality, even after adjusting for conventional risk factors. In this review the available epidemiological evidence linking PTB to future cardiovascular risk is summarised, the proposed biological mechanisms, including persistent inflammation, endothelial dysfunction, oxidative stress, placental vascular abnormalities, and genetic or epigenetic alterations are explored, and their clinical implications are discussed. Finally, the authors outline recommendations consistent with the recent European Society of Cardiology and American Heart Association guidelines. Recognising PTB as an independent cardiovascular risk marker underscores the need to integrate obstetric history into cardiovascular risk assessment and prevention strategies. Incorporating obstetric history into routine care offers a crucial opportunity to improve cardiovascular outcomes and promote long-term health in women who experience PTB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.